|Day Low/High||97.00 / 97.89|
|52 Wk Low/High||58.59 / 97.15|
The forces that artificially impacted the marketplace return to normal; so will the marketplace itself.
With thirty minutes to go: * Watching CNBC and the rest of the business media, one would conclude that "everyone is in the pool." It is, as one talking head just declared..."a buy/buy scenario." (Enough said/written). * The bond market's decline was...
The Summit, N.J.-based firm said Thursday that it was discontinuing the GED-0301 (mongersen) Phase 3 Revolve study in Crohn's disease and the extension trial.
Look at this recent pullback as an opportunity for a buy-side entry.
You have options when trading options, so don't give up your leverage or advantage too soon.
"While options can give market participants the protection they are intended to provide, they can also increase the degree of a counter move, once it gets going, as those who wrote the protection scramble to unwind their own exposure." -- Kass Diary...
Morgan Stanley analysts upgraded shares of Biogen and downgraded shares of Celgene over concerns of generic drug pressures. TheStreet's Jim Cramer called these moves "useless."
As a Miami resident, I've learned the value of hurricane preparation and the 'Jensen Rules'.
As a Florida resident, I've learned the value of preparation and the 'Jensen Rules'.
This team is playoff-ready and built for the ages.
Buying's good for the acquirers, which should give other companies ideas.
Prospects for acquisition activity in the sector are improving.
"Yeah, well, that's just, like, your opinion, man." -- The Dude, The Big Lebowski Strikes and gutters today -- in a market characterized by winners and losers and weakening breadth. Ups and downs. Amazon's shares may be signaling there is no fun,...
Nothing's happening, but that doesn't mean you have to make something happen.
The market seems fully valued, so I'm building up cash as we head into historically volatile months.
CELG looks like it has a promising future, according to the charts.
The story's in the past with nothin' to recall, I've got my life to live and I don't need you at all. The roller-coaster ride we took is nearly at an end, I bought my ticket with my tears, that's all I'm gonna spend. -- The Cyrkle, Red Rubber Ball M...
Multiples have become quite rich and dysfunction in Washington could end up biting the markets.
Coming up on the two-hour mark on trading. The market is down slightly down across the board, with Nasdaq being affected by disappointing results from Starbucks and Amazon . The failure to even getting a "skinny" repeal and replacement of the Afford...
It is good to be sitting in for Doug Kass here on the Daily Diary as we look to end the trading week on a positive note. It is also good to see the Yankees start to win close games again after losing so many of them in the weeks leading into the All...
After 90 minutes of trading here are some market features: * Bonds are getting schmeissed. The 10-year U.S. note yield is close to 2.32% and the long bond is knocking on the door of 3.00%. A possible equity market headwind. * Retail still has a ni...